Thyrocare Technologies’ shares slumped 66.7% to ₹492 on Friday as they began trading ex-bonus for the recently announced 2:1 bonus issue. The sharp drop is a normal adjustment due to the bonus issue and doesn’t indicate any deterioration in fundamentals.